Loss of DCC expression and glioma progression

Cancer Research

Volumn 57, Issue 3, 1997, Pages 382-386

  Reyes Mugica, Miguel ^a   Rieger Christ, Kimberly ^a   Ohgaki, Hiroko ^c   Ekstrand, Bradley C ^a   Helie, Mary ^a   Kleinman, George ^d   Yahanda, Alan ^e   Fearon, Eric R ^f   Kleihues, Paul ^c   Reale, Michael A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d BRIDGEPORT HOSPITAL   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTROCYTOMA; CANCER GROWTH; CHROMOSOME 18Q; GENE ACTIVATION; GLIOBLASTOMA; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ANIMALS; ASTROCYTES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DCC; GLIOBLASTOMA; GLIOMA; HUMANS; MICE;

EID: 0031050237     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomas, G., Kinzler, K. W., and Vogelstein B. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (Washington DC), 247: 49-56, 1990.
2. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Lepper, M., Nakamura, Y., White, R., Smits, A. M. M., and Bos, J. L. Genetic alterations during colorectal tumor development. N. Engl. J. Med., 319: 525-532, 1988.
3. Cho, K. R., and Fearon, E. R. DCC: a potential link between tumor suppressor genes and altered cell surface interactions in cancer. Curr. Opin. Genet, Dev., 5: 72-78, 1995.
4. Thiagalingam, S., Lengauer, C., Leach, F. S., Schutte, M., Hahn, S. A., Overhauser, J., Willson, J. K. V., Markowitz, S., Hamilton, S. R., Kern, S. E., Kinzler, K. W., and Vogelstein, B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet., 13: 343-346, 1996.
5. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsue, L-C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 86: 543-552, 1996.
6. Jen, J., Kim, H., Piantadosi, S., Liu, Z-F., Levitt, R. C., Sistonen, P., Kinzler, K. W., Vogelstein, B., and Hamilton, S. R. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl, J. Med., 331: 213-221, 1994.
7. Shibata, D., Reale, M. A., Lavin, P., Silverman, M., Fearon, E. R., Steele, G., Jr., Jessup, M. J., Loda, M., and Summerhayes, I. C. Loss of DCC expression and prognosis in colorectal cancer. N. Engl. J. Med., 335: 1727-1732, 1996.
8. Cho, K. R., Oliner, J. D., Simons, J. W., Hedrick, L., Fearon, E. R., Preisinger, A. C., Hedge, P., Silverman, G. A., and Vogelstein, B. The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics, 19: 525-531, 1994.
9. Takita, J., Hayashi, Y., Kohno, T., Shiseki, M., Yamaguchi, N., Hanada, R., Yamamoto, K., and Yokota, J. Allelotype of neuroblastoma. Oncogene, 11: 1829-1834, 1995.
10. Reale, M. A., Reyes-Mugica, M., Pierceall, W. E., Rubinstein, M. C., Hedrick, L., Cohn, S. L., Nakagawara, A., Brodeur, G. M., and Fearon, E. R. Loss of DCC expression in neuroblastoma is associated with disease dissemination. Clin. Cancer Res., 2: 1097-1102, 1996.
11. Klingelhutz, A. J., Hedrick, L., Cho, K. R., and McDougal, J. K. The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene, 10: 1581-1586, 1995.
12. Reale, M. A., Hu, G., Getzenberg, R. H., Zafar, A. I., Levine, S. M., and Fearon, E. R. Expression of the deleted in colorectal cancer (DCC) tumor suppressor gene in cell lines and normal and malignant tissues: evidence for alternative splicing. Cancer Res., 54: 4493-4501, 1994.
13. Pierceall, W. E., Reale, M. A., Cho, K. R., and Fearon, E. R. Expression of a Xenopus laevis homologue of the deleted in colorectal cancer (DCC) tumor suppressor gene is developmentally regulated. Dev. Biol., 166: 654-665, 1994.
14. Scheck, A. C., and Coons, S. W. Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res., 53: 5605-5609, 1993.
15. Ekstrand, B. C., Mansfield, T., Bigner, S., and Fearon, E. R. DCC expression is altered by multiple mechanisms in human brain tumors. Oncogene, 11: 2393-2402, 1995.
16. Watanabe, K., Tachibana, O., Sato, K., Yonekawa, Y., Kleihues, P., and Ohgaki, H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol., 6: 217-224, 1996.
17. Bogler, O., Huang, H-J.S., and Cavenee, W. K. Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation. Cancer Res., 55: 2746-2751, 1995.
18. Yahanda, A. M., Bruner, J. M., Donehower, L. A., and Morrison, R. S. Astrocytes derived from p53-deficient mice provide a multi-step in vitro model for development of malignant gliomas. Mol. Cell. Biol., 15: 4249-4259, 1995.
19. Louis, D. N., and Gusella, J. F. A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet., 11: 412-415, 1995.
20. Kleihues, P., Soylemezoglu, F., Schauble, B., Scheithauer, B. W., and Burger, P. C. Histopathology, classification, and grading of gliomas. Glia, 15: 211-221, 1995.
21. Weinberg, R. A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res., 49: 3713-3721, 1989.
22. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
23. Cavenee, W. K. Accumulation of genetic defects during astrocytoma progression. Cancer, 70(Suppl.): 1788-1793, 1992.
24. Piepmeier, J., Christopher, S., Spencer, D., Byrne, T., Kim, J., Knisely, J. P., Lacy, J., Tsukerman, L., and Makuch, R. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery (Baltimore), 38: 872-879, 1996.